Clinical Efficacy of a 24-months Course of Lamivudine Therapy in Patients with HBeAg Negative Chronic Hepatitis B: A Long-term Prospective Study

The optimal duration of oral nucleos(t)ide analogue therapy for HBeAg negative chronic hepatitis B (CHB) has not been defined. The aim of this study was to investigate the clinical efficacy of 24-months course of lamivudine therapy in patients with HBeAg negative CHB in Korea. A total of 50 Korean p...

Descripción completa

Detalles Bibliográficos
Autores principales: Paik, Yong Han, Kim, Ja Kyung, Kim, Do Young, Park, Jun Yong, Ahn, Sang Hoon, Han, Kwang-Hyub, Chon, Chae Yoon, Lee, Kwan Sik
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877218/
https://www.ncbi.nlm.nih.gov/pubmed/20514309
http://dx.doi.org/10.3346/jkms.2010.25.6.882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877218/
https://www.ncbi.nlm.nih.gov/pubmed/20514309
http://dx.doi.org/10.3346/jkms.2010.25.6.882

Ejemplares similares